Exclusive Global 20 Seats, China's Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone

Exclusive Global 20 Seats, China's Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone

SUZHOU, China, May 28, 2025 /PRNewswire/ -- In the newly announced entry list of the Inspiration Hive zone at the 2025 New York Society of Cosmetic Chemists (NYSCC) exhibition, Kintor's innovative ingredient KT-939 has been selected as the only...

NEC highlights retail solutions at NRF 2025 APAC in Singapore

NEC highlights retail solutions at NRF 2025 APAC in Singapore

- Leveraging data and AI to create a more enriched future - TOKYO, May 27, 2025 /PRNewswire/ -- NEC Corporation (NEC; TSE: 6701) will demonstrate advanced retail solutions at "NRF 2025: Retail's Big Show Asia Pacific" (NRF 2025 APAC) at Hall A-C,...

Kingston Powers Tomorrow: Enabling the Future of AI with High-Performance Solutions at COMPUTEX 2025

Kingston Powers Tomorrow: Enabling the Future of AI with High-Performance Solutions at COMPUTEX 2025

TAIPEI, May 20, 2025 /PRNewswire/ -- Kingston Technology, a world leader in memory products and technology solutions, returns to COMPUTEX 2025 with the theme "Kingston Powers Tomorrow: Committed to the AI Future . " Staying true to its Built on...

Gemtek Technology to Showcase 800G Optical Module, Software Cloud, and AI Router at COMPUTEX TAIPEI 2025

Gemtek Technology to Showcase 800G Optical Module, Software Cloud, and AI Router at COMPUTEX TAIPEI 2025

TAIPEI, May 16, 2025 /PRNewswire/ -- Gemtek Technology is set to showcase a powerful lineup of next-generation technologies at COMPUTEX TAIPEI 2025, taking place from May 20 to 23 at the Taipei Nangang Exhibition Center. Gemtek, a global leader in...

Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings

Amorepacific and Johns Hopkins School of Medicine's Joint Research Program 'NBRI' Participants Present Latest Findings

Skin anti-aging and immunity effects of Amorepacific's two proprietary ingredients, 'RE.D Flavonoid' and 'Senomune' revealed at the 2025 SID Annual Meeting SEOUL, South Korea, May 16, 2025 /PRNewswire/ -- Amorepacific has demonstrated the efficacy...

JX Luxventure Group Soars with 57% Revenue Surge and Sustained Profitability in FY 2024 Results

JX Luxventure Group Soars with 57% Revenue Surge and Sustained Profitability in FY 2024 Results

HAIKOU, China, May 15, 2025 /PRNewswire/ -- JX Luxventure Group Inc. (Nasdaq: JXG) (the "Company"), a company in the wholesale trade sector specializing in duty-free and cross-border consumer goods, as well as providing integrated solutions in...

TCL CSOT Unveils Industry-Defining Advances Across Display Technologies at SID Display Week 2025

TCL CSOT Unveils Industry-Defining Advances Across Display Technologies at SID Display Week 2025

SAN JOSE, Calif., May 14, 2025 /PRNewswire/ -- TCL CSOT, a global leader in advanced display technologies, made a commanding appearance at SID Display Week 2025, the premier global summit for the display industry. Showcasing a comprehensive...

LG OLED X STEVEN HARRINGTON AT FRIEZE NEW YORK: WHERE VIBRANT POP ART MEETS THE TRANSPARENT OLED TV

LG OLED X STEVEN HARRINGTON AT FRIEZE NEW YORK: WHERE VIBRANT POP ART MEETS THE TRANSPARENT OLED TV

Experience a Captivating Fusion of Art and Technology as Steven Harrington's Whimsical Pop Art Comes to Life on LG's Most Advanced TVs for 2025 SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- LG Electronics (LG) is partnering with iconic psychedelic...

ArkBio Announces Positive Phase II Results of AK3280 for treatment of Idiopathic Pulmonary Fibrosis (IPF)

ArkBio Announces Positive Phase II Results of AK3280 for treatment of Idiopathic Pulmonary Fibrosis (IPF)

SHANGHAI, May 7, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of idiopathic pulmonary fibrosis (IPF). The...

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 7, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • menu
    menu